Children's Specialty Hospitals in the US - Industry Market Research Report
Children's Specialty Hospitals in the US
Though they represent less than 5% of all US hospitals, children's specialty hospitals are critical to pediatric healthcare. And despite COVID-19 disruptions, the industry experienced growth due to the inelastic demand for children's health services. While the pandemic raised operating costs, telemedicine and government support helped offset significant declines in demand and revenue. The volatility in revenue and expenses caused by the COVID-19 pandemic did not affect industry-wide revenue, which has been declining at a CAGR of only 0.9% over the past five years, and is expected to total $41.2 billion in 2023. In the same year, revenue will jump an estimated 1.2% alone.
This industry includes hospitals that provide diagnostic and medical treatment (surgical and nonsurgical) to inpatients who are typically aged 21 and younger. These hospitals treat a specific type of disease or medical condition (except psychiatric conditions or substance abuse), maintain inpatient beds and provide patients with food services and other services (e.g. outpatient services, X-ray services, laboratory services, operating room services and pharmacy services).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares."
ABOUT THIS INDUSTRY
Industry Definition Main Activities Similar Industries Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary Key External Drivers Current Performance Industry Outlook Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain Products & Services Demand Determinants Major Markets International Trade Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration Key Success Factors Cost Structure Benchmarks Basis of Competition Barriers to Entry Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity Technology & Systems Revenue Volatility Regulation & Policy Industry Assistance